Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8757 |
High Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.8712 |
High Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8266 |
Intermediate Similarity |
NPD7472 |
Approved |
0.8266 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.8256 |
Intermediate Similarity |
NPD7228 |
Approved |
0.8256 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.8253 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.8229 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8218 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.8208 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.8208 |
Intermediate Similarity |
NPD7054 |
Approved |
0.8182 |
Intermediate Similarity |
NPD8313 |
Approved |
0.8182 |
Intermediate Similarity |
NPD8312 |
Approved |
0.8171 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.8156 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.8125 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.8107 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8095 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.8066 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.8059 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.8036 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.8035 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8035 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8035 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.8023 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7976 |
Intermediate Similarity |
NPD37 |
Approved |
0.7941 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7941 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7941 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7914 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7911 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7888 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7886 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7865 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7865 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7861 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7861 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7797 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.779 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7784 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7765 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7765 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7751 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7727 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7719 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.767 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.764 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7633 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7616 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7614 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7605 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7604 |
Intermediate Similarity |
NPD8319 |
Approved |
0.7604 |
Intermediate Similarity |
NPD8320 |
Phase 1 |
0.7594 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7594 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7586 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7566 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.7566 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.756 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7554 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7552 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7529 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7514 |
Intermediate Similarity |
NPD2801 |
Approved |
0.75 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7487 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7487 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7487 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7487 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7487 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7487 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7487 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7486 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7471 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7462 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7462 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7461 |
Intermediate Similarity |
NPD7680 |
Approved |
0.7435 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.7429 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7425 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7423 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7423 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7411 |
Intermediate Similarity |
NPD7874 |
Approved |
0.7411 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.7407 |
Intermediate Similarity |
NPD943 |
Approved |
0.7399 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7396 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7394 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7394 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7394 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7394 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7391 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7371 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7371 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7371 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7371 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7371 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7354 |
Intermediate Similarity |
NPD6212 |
Phase 3 |
0.7354 |
Intermediate Similarity |
NPD6213 |
Phase 3 |
0.7354 |
Intermediate Similarity |
NPD6214 |
Clinical (unspecified phase) |
0.7325 |
Intermediate Similarity |
NPD9269 |
Phase 2 |
0.7321 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.7314 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.731 |
Intermediate Similarity |
NPD1512 |
Approved |
0.731 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.7305 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7303 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7283 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7283 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7257 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7251 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7251 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7251 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7251 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7231 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.7229 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7219 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7202 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.72 |
Intermediate Similarity |
NPD7801 |
Approved |
0.7195 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7195 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7168 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7143 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7136 |
Intermediate Similarity |
NPD8155 |
Clinical (unspecified phase) |
0.7126 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7126 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7126 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7093 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7074 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.707 |
Intermediate Similarity |
NPD9268 |
Approved |
0.7059 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7052 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7052 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7045 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7035 |
Intermediate Similarity |
NPD7211 |
Clinical (unspecified phase) |
0.7018 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7018 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7012 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.6994 |
Remote Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.6978 |
Remote Similarity |
NPD8127 |
Discontinued |
0.6959 |
Remote Similarity |
NPD6674 |
Discontinued |
0.6954 |
Remote Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.6951 |
Remote Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.694 |
Remote Similarity |
NPD7229 |
Phase 3 |
0.6911 |
Remote Similarity |
NPD8434 |
Phase 2 |
0.6902 |
Remote Similarity |
NPD5242 |
Approved |
0.6902 |
Remote Similarity |
NPD3926 |
Phase 2 |
0.6893 |
Remote Similarity |
NPD3226 |
Approved |
0.6889 |
Remote Similarity |
NPD5353 |
Approved |
0.6886 |
Remote Similarity |
NPD1240 |
Approved |
0.6882 |
Remote Similarity |
NPD2935 |
Discontinued |
0.6882 |
Remote Similarity |
NPD2796 |
Approved |
0.6882 |
Remote Similarity |
NPD7177 |
Discontinued |
0.6881 |
Remote Similarity |
NPD7585 |
Approved |
0.6867 |
Remote Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.6848 |
Remote Similarity |
NPD5710 |
Approved |
0.6848 |
Remote Similarity |
NPD5711 |
Approved |
0.6845 |
Remote Similarity |
NPD7930 |
Approved |
0.6832 |
Remote Similarity |
NPD7583 |
Approved |
0.6821 |
Remote Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.6818 |
Remote Similarity |
NPD6273 |
Approved |
0.6805 |
Remote Similarity |
NPD1607 |
Approved |
0.6802 |
Remote Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.6798 |
Remote Similarity |
NPD3455 |
Phase 2 |
0.6792 |
Remote Similarity |
NPD9545 |
Approved |
0.6784 |
Remote Similarity |
NPD1551 |
Phase 2 |
0.6776 |
Remote Similarity |
NPD919 |
Approved |
0.6765 |
Remote Similarity |
NPD4978 |
Clinical (unspecified phase) |
0.6755 |
Remote Similarity |
NPD8470 |
Clinical (unspecified phase) |
0.6753 |
Remote Similarity |
NPD4287 |
Approved |
0.6749 |
Remote Similarity |
NPD7584 |
Approved |
0.6747 |
Remote Similarity |
NPD4908 |
Phase 1 |
0.6746 |
Remote Similarity |
NPD1933 |
Approved |
0.6745 |
Remote Similarity |
NPD5619 |
Clinical (unspecified phase) |
0.6729 |
Remote Similarity |
NPD8059 |
Phase 3 |
0.6729 |
Remote Similarity |
NPD8058 |
Clinical (unspecified phase) |
0.6716 |
Remote Similarity |
NPD5006 |
Approved |
0.6716 |
Remote Similarity |
NPD5005 |
Approved |
0.6707 |
Remote Similarity |
NPD5952 |
Clinical (unspecified phase) |
0.6703 |
Remote Similarity |
NPD4288 |
Approved |
0.6702 |
Remote Similarity |
NPD7549 |
Discontinued |
0.6702 |
Remote Similarity |
NPD7799 |
Discontinued |
0.67 |
Remote Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.67 |
Remote Similarity |
NPD7999 |
Approved |
0.6687 |
Remote Similarity |
NPD9494 |
Approved |
0.6686 |
Remote Similarity |
NPD6099 |
Approved |
0.6686 |
Remote Similarity |
NPD6100 |
Approved |
0.6667 |
Remote Similarity |
NPD4160 |
Clinical (unspecified phase) |
0.6667 |
Remote Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.6667 |
Remote Similarity |
NPD1470 |
Approved |
0.6667 |
Remote Similarity |
NPD7097 |
Phase 1 |
0.6667 |
Remote Similarity |
NPD6798 |
Discontinued |
0.6649 |
Remote Similarity |
NPD8368 |
Discontinued |
0.6647 |
Remote Similarity |
NPD447 |
Suspended |
0.6647 |
Remote Similarity |
NPD2029 |
Clinical (unspecified phase) |
0.6647 |
Remote Similarity |
NPD2346 |
Discontinued |
0.663 |
Remote Similarity |
NPD6386 |
Approved |
0.663 |
Remote Similarity |
NPD6385 |
Approved |
0.6617 |
Remote Similarity |
NPD8486 |
Clinical (unspecified phase) |
0.6615
|
Remote Similarity |
NPD6842 |
Approved |